Fresenius Medical Care AG & Co. KGaA
FMS Healthcare Medical Care Facilities
Fresenius Medical Care AG & Co. KGaA’s revenue for fiscal 2025 (year ended December 2025) was $22.2 billion, up 6.13% from fiscal 2024.
- Revenue
- −0.49%
- EPS
- −10.6%
- Free cash flow
- −3.47%
- Total debt
- +8.09%
Quarter to September 2026, against a year earlier
Follow FMS
Alert me
Fresenius Medical Care AG & Co. KGaA (FMS) EV/EBITDA
As of 5 November 2026, Fresenius Medical Care AG & Co. KGaA (FMS) trades at a EV/EBITDA of 5.1×. Over the past ten years it has ranged from 4.2× (October 2022) to 12.2× (January 2018); the current reading is higher than 8% of that period. That is below the Medical Care Facilities industry median of 11.9× and below the Healthcare sector median of 8.4×.
EV/EBITDA, daily
Embed this chart
Annual newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| FY2025 | 5.3× | (2.63%) |
| FY2024 | 5.4× | (5.05%) |
| FY2023 | 5.7× | 17.59% |
| FY2022 | 4.8× | (27.31%) |
| FY2021 | 6.7× | (3.35%) |
| FY2020 | 6.9× | (4.80%) |
| FY2019 | 7.2× | 22.67% |
| FY2018 | 5.9× | (47.53%) |
| FY2017 | 11.3× | 13.93% |
| FY2016 | 9.9× | (10.44%) |
Quarterly newest first
| Period | EV/EBITDA | Change |
|---|---|---|
| Sep 2026 | 4.9× | (0.89%) |
| Jun 2026 | 4.9× | (0.96%) |
| Mar 2026 | 5.0× | (5.26%) |
| Dec 2025 | 5.3× | (14.09%) |
| 43 more quarters | Free account |
Against its own ten years
EV/EBITDA against peers
| Company | EV/EBITDA |
|---|---|
| THC Tenet Healthcare Corporation compare | 4.7× |
| FMS Fresenius Medical Care AG & Co. KGaA | 5.1× |
| UHS Universal Health Services, Inc. compare | 6.4× |
| DVA DaVita Inc. compare | 8.0× |
| EHC Encompass Health Corporation compare | 10.7× |
| CON Concentra Group Holdings Parent, Inc. compare | 14.0× |
| PACS PACS Group, Inc. compare | 16.2× |
| CHE Chemed Corporation compare | 16.3× |
| ENSG The Ensign Group, Inc. compare | 16.4× |
| Medical Care Facilities industry median | 11.9× |
| Healthcare sector median | 8.4× |
| Market median | 10.9× |
What EV/EBITDA is
Enterprise Value over EBITDA tells an investor how the market values a whole company, with debt added and cash taken off, against its operating earnings.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ EBITDA (TTM)
More on FMS
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Altman Z-score
- Beneish M-score
- The full statement